From the publishers of JADPRO

MPN Resource Center

Advertisement

Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives

This review article explores the role of JAK inhibitors in the management MPNs today, including approved therapies and ongoing research into newer agents, associated efficacy and safety, and potential combination therapies with novel agents.

International Journal of Hematology
Advertisement
News & Literature Highlights
Advertisement
Advertisement